BARRIER THERAPEUTICS INC 4
Accession 0001181431-04-023343
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 2:52 PM ET
Size
30.0 KB
Accession
0001181431-04-023343
Insider Transaction Report
- Conversion
Series C Preferred Stock
2004-04-28−10,235→ 0 total→ Common Stock (5,117 underlying) - Conversion
Series C Preferred Stock
2004-04-28−591,775→ 0 total→ Common Stock (295,887 underlying) - Conversion
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total→ Common Stock (1,638,330 underlying) - Conversion
Series B Preferred Stock
2004-04-28−56,674→ 0 total→ Common Stock (28,337 underlying) - Conversion
Common Stock
2004-04-28+1,934,217→ 1,934,217 total - Conversion
Common Stock
2004-04-28+33,454→ 33,454 total
- Conversion
Common Stock
2004-04-28+1,934,217→ 1,934,217 total - Conversion
Series B Preferred Stock
2004-04-28−56,674→ 0 total→ Common Stock (28,337 underlying) - Conversion
Common Stock
2004-04-28+33,454→ 33,454 total - Conversion
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total→ Common Stock (1,638,330 underlying) - Conversion
Series C Preferred Stock
2004-04-28−10,235→ 0 total→ Common Stock (5,117 underlying) - Conversion
Series C Preferred Stock
2004-04-28−591,775→ 0 total→ Common Stock (295,887 underlying)
- Conversion
Series C Preferred Stock
2004-04-28−10,235→ 0 total→ Common Stock (5,117 underlying) - Conversion
Common Stock
2004-04-28+1,934,217→ 1,934,217 total - Conversion
Common Stock
2004-04-28+33,454→ 33,454 total - Conversion
Series C Preferred Stock
2004-04-28−591,775→ 0 total→ Common Stock (295,887 underlying) - Conversion
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total→ Common Stock (1,638,330 underlying) - Conversion
Series B Preferred Stock
2004-04-28−56,674→ 0 total→ Common Stock (28,337 underlying)
- Conversion
Common Stock
2004-04-28+1,934,217→ 1,934,217 total - Conversion
Series C Preferred Stock
2004-04-28−10,235→ 0 total→ Common Stock (5,117 underlying) - Conversion
Common Stock
2004-04-28+33,454→ 33,454 total - Conversion
Series C Preferred Stock
2004-04-28−591,775→ 0 total→ Common Stock (295,887 underlying) - Conversion
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total→ Common Stock (1,638,330 underlying) - Conversion
Series B Preferred Stock
2004-04-28−56,674→ 0 total→ Common Stock (28,337 underlying)
- Conversion
Common Stock
2004-04-28+33,454→ 33,454 total - Conversion
Series C Preferred Stock
2004-04-28−10,235→ 0 total→ Common Stock (5,117 underlying) - Conversion
Series B Preferred Stock
2004-04-28−56,674→ 0 total→ Common Stock (28,337 underlying) - Conversion
Common Stock
2004-04-28+1,934,217→ 1,934,217 total - Conversion
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total→ Common Stock (1,638,330 underlying) - Conversion
Series C Preferred Stock
2004-04-28−591,775→ 0 total→ Common Stock (295,887 underlying)
- Conversion
Common Stock
2004-04-28+1,934,217→ 1,934,217 total - Conversion
Series C Preferred Stock
2004-04-28−591,775→ 0 total→ Common Stock (295,887 underlying) - Conversion
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total→ Common Stock (1,638,330 underlying) - Conversion
Series B Preferred Stock
2004-04-28−56,674→ 0 total→ Common Stock (28,337 underlying) - Conversion
Common Stock
2004-04-28+33,454→ 33,454 total - Conversion
Series C Preferred Stock
2004-04-28−10,235→ 0 total→ Common Stock (5,117 underlying)
- Conversion
Common Stock
2004-04-28+1,934,217→ 1,934,217 total - Conversion
Common Stock
2004-04-28+33,454→ 33,454 total - Conversion
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total→ Common Stock (1,638,330 underlying) - Conversion
Series C Preferred Stock
2004-04-28−10,235→ 0 total→ Common Stock (5,117 underlying) - Conversion
Series B Preferred Stock
2004-04-28−56,674→ 0 total→ Common Stock (28,337 underlying) - Conversion
Series C Preferred Stock
2004-04-28−591,775→ 0 total→ Common Stock (295,887 underlying)
- Conversion
Series C Preferred Stock
2004-04-28−591,775→ 0 total→ Common Stock (295,887 underlying) - Conversion
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total→ Common Stock (1,638,330 underlying) - Conversion
Series B Preferred Stock
2004-04-28−56,674→ 0 total→ Common Stock (28,337 underlying) - Conversion
Series C Preferred Stock
2004-04-28−10,235→ 0 total→ Common Stock (5,117 underlying) - Conversion
Common Stock
2004-04-28+1,934,217→ 1,934,217 total - Conversion
Common Stock
2004-04-28+33,454→ 33,454 total
- Conversion
Series C Preferred Stock
2004-04-28−10,235→ 0 total→ Common Stock (5,117 underlying) - Conversion
Common Stock
2004-04-28+1,934,217→ 1,934,217 total - Conversion
Common Stock
2004-04-28+33,454→ 33,454 total - Conversion
Series B Preferred Stock
2004-04-28−56,674→ 0 total→ Common Stock (28,337 underlying) - Conversion
Series C Preferred Stock
2004-04-28−591,775→ 0 total→ Common Stock (295,887 underlying) - Conversion
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total→ Common Stock (1,638,330 underlying)
Footnotes (3)
- [F1]All of the outstanding shares of the Issuer's Series B and Series C Convertible Preferred Stock converted automatically on a 2-for-1 basis into Common Stock of the Issuer just prior to the Issuer's initial public offering.
- [F2]See Exhibit 99.1. Shares are held by TL Ventures V L.P. ("TL V"). TL Ventures V Management L.P. ("TLV Mgmt L.P"), the general partner of TL V, TL Ventures V LLC ("TLV LLC"), the general partner of TLV Mgmt L.P., and Robert E. Keith, Jr., Gary J. Anderson, Mark J. DeNino, Christopher Moller Ph.D, Anthony Craig, Christopher J. Davis and Robert N. Verratti, the members of the executive board of TLV LLC, together with Dr. Ostro, may be deemed to share voting and dispositive power over the shares held by TL V. Such persons and entities disclaim beneficial ownership of shares held by TL V except to the extent of any pecuniary interest therein.
- [F3]See Exhibit 99.1. Shares are held by TL Ventures V Interfund L.P. ("TL V Interfund"). TL V LLC, the general partner of TL V Interfund, and Robert E. Keith, Jr., Gary J. Anderson, Mark J. DeNino, Christopher Moller Ph.D, Anthony Craig, Christopher J. Davis and Robert N. Verratti, the members of the executive board of TL V LLC, together with Dr. Ostro, may be deemed to share voting and dispositive power over the shares held by TL V Interfund. Such persons and entities disclaim beneficial ownership of shares held by TL V Interfund except to the extent of any pecuniary interest therein.
Issuer
BARRIER THERAPEUTICS INC
CIK 0001173657
Related Parties
1- filerCIK 0001173657
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 2:52 PM ET
- Size
- 30.0 KB